Amphastar Pharmaceuticals Inc v. Aventis Pharma SA
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA
AMPHASTAR PHARMACEUTICALS
Case No. 5:09-cv-00023-SHK
INC.,
Plaintiff,
OPINION AND ORDER v. 14 AVENTIS PHARMA S.A., et al., 15 Defendants. 16 17 Defendants Aventis Pharma S.A., Aventis Pharmaceuticals, Inc., and Sanofi- Aventis S.A. (collectively “Defendants”) filed their Supplemental Submission Pursuant to the Court’s November 13, 2020 Fee Amount Order (“Submission” or “Sub.”) against Plaintiff Amphastar Pharmaceuticals, Inc. (“Plaintiff”). Electronic Case Filing Number (“ECF No.”) 634, Sub. Pursuant to 28 U.S.C. § 636(c), the parties have consented to the jurisdiction of the undersigned United States Magistrate Judge. See ECF No. 607, Statement of Consent to Proceed before a United States Magistrate Judge (“Consent Statement”). For the reasons discussed below, the Court GRANTS Defendants’ Submission in part. / / / I. BACKGROUND The procedural history of this case, which the…